Skip to search formSkip to main contentSkip to account menu

Meningococcal Conjugate Vaccine MCV4

Known as: MCV4, Meningococcal Conjugate Vaccine MCV-4, Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugated Vaccine 
A conjugate vaccine of meningococcal polysaccharide used for active immunization against invasive meningococcal disease caused by Neisseria… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVES To examine state-level associations between voting patterns and adolescent coverage for at least 1 dose of human… 
2012
2012
ABSTRACT Saudi Arabian children respond poorly to 2 doses of meningococcal quadrivalent polysaccharide vaccine (MPSV4) when given… 
Review
2011
Review
2011
Objectives. We compared (1) characteristics of adolescents who are and are not entitled to receive free vaccines from the… 
2008
2008
We describe a multi‐center post‐marketing safety study that uses distributed data methods to minimize the need for covered… 
2008
2008
Invasive meningococcal disease occurs worldwide causing an estimated 50,000–135,000 deaths each year in addition to significant… 
Review
2008
Review
2008
Background: Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. Since 1981, a tetravalent meningococcal… 
2006
2006
  • 2006
  • Corpus ID: 23312301
During June-August 2005, CDC and the Food and Drug Administration (FDA) were notified of seven clusters of inadvertent…